World Buiatrics Congress 2016 (WBC 2016) Contact WBC 2016
The World’s Premier Cattle Health Congress
July 3rd - 8th 2016 Dublin, Ireland

Boehringer Ingelheim Animal Health is committed to providing leading solutions to prevent, treat and cure animal diseases. Every year, we invest more than 10 percent of our net sales in Animal Health to do research at the highest level.

At Boehringer Ingelheim Animal Health, more than 3,500 employees worldwide work on the research and development of new medicines and procedures to keep our animal patients healthy. We are driven by the wish to improve animal welfare as an integral part of a healthy future for mankind.

Through its commitment to the Science of Healthier Animals™, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in 150 markets.

For more information, visit www.msd-animal-health.com or connect with us on LinkedIn.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

HIPRA is a veterinary pharmaceutical company dedicated to the research, production and marketing of products for Animal Health.

At HIPRA we are convinced that the future lies in prevention. We are specialists in developing innovative preventive solutions that make it possible to identify existing threats on any livestock farm before they occur, in such a way that we can act to prevent them or minimize their effects.

We have a broad range of highly innovative Biological products, an advanced diagnostic service and our own line of Diagnostic kits.

We are located in more than 20 countries with our own commercial subsidiaries and production plants strategically situated in Europe and America. Likewise, our large global distribution network enables our products to reach customers in more than 100 countries on all five continents.

At HIPRA we maintain a commitment to excellence, to service to livestock farms, to our people and to social, economic and environmental improvement.